<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yao W</submitter><funding>Department of Science and Technology of Henan Province</funding><funding>Applied Research in the Diagnosis and Treatment of Osteosarcoma</funding><pagination>893-905</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7893995</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>112(2)</volume><pubmed_abstract>Mounting research papers have suggested that long non-coding RNAs (lncRNAs) elicit important functions in the progression of osteosarcoma (OS). This study focused on the role of TNK2-AS1 in OS. TNK2-AS1 was powerfully expressed in OS tissues and cell lines. In addition, TNK2-AS1 downregulation inhibited proliferative, migratory, and invasive capacities while promoting apoptosis in OS cells. miR-4319 was removed by TNK2-AS1 and therefore TNK2-AS1 elevated WDR1 expression in OS cells. miR-4319 had an inhibitory influence on OS progression, while WDR1 was a contributor to OS progression. Rescue assays certified that TNK2-AS1 promoted malignant phenotypes in vitro and the growth in vivo of OS cells by upregulating WDR1. In depth, we found that YY1 accelerated the transcription of TNK2-AS1 in O</pubmed_abstract><journal>Cancer science</journal><pubmed_title>TNK2-AS1 upregulated by YY1 boosts the course of osteosarcoma through targeting miR-4319/WDR1.</pubmed_title><pmcid>PMC7893995</pmcid><funding_grant_id>182102410001</funding_grant_id><funding_grant_id>2018.1-2019.12</funding_grant_id><pubmed_authors>Hou J</pubmed_authors><pubmed_authors>Yan Q</pubmed_authors><pubmed_authors>Du X</pubmed_authors><pubmed_authors>Yao W</pubmed_authors></additional><is_claimable>false</is_claimable><name>TNK2-AS1 upregulated by YY1 boosts the course of osteosarcoma through targeting miR-4319/WDR1.</name><description>Mounting research papers have suggested that long non-coding RNAs (lncRNAs) elicit important functions in the progression of osteosarcoma (OS). This study focused on the role of TNK2-AS1 in OS. TNK2-AS1 was powerfully expressed in OS tissues and cell lines. In addition, TNK2-AS1 downregulation inhibited proliferative, migratory, and invasive capacities while promoting apoptosis in OS cells. miR-4319 was removed by TNK2-AS1 and therefore TNK2-AS1 elevated WDR1 expression in OS cells. miR-4319 had an inhibitory influence on OS progression, while WDR1 was a contributor to OS progression. Rescue assays certified that TNK2-AS1 promoted malignant phenotypes in vitro and the growth in vivo of OS cells by upregulating WDR1. In depth, we found that YY1 accelerated the transcription of TNK2-AS1 in O</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2026-05-09T08:55:50.638Z</modification><creation>2021-03-05T09:11:47Z</creation></dates><accession>S-EPMC7893995</accession><cross_references><pubmed>33164271</pubmed><doi>10.1111/cas.14727</doi></cross_references></HashMap>